Use of omalizumab for management of idiopathic anaphylaxis
Lauren W. Kaminsky, Kestutis Aukstuolis, Daniel Petroni, Taha Al‐Shaikhly
Topics & Concepts
OmalizumabMedicineAnaphylaxisMast cellRetrospective cohort studyInternal medicineImmunoglobulin EAllergyImmunologyAntibodyMast cells and histamineUrticaria and Related ConditionsDrug-Induced Adverse Reactions